CORBF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CORBF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Global Cord Blood has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Global Cord Blood's Piotroski F-Score or its related term are showing as below:
The historical data trend for Global Cord Blood's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Cord Blood Annual Data | |||||||||||||||||||||
Trend | Mar13 | Mar14 | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | |||||||||||
Piotroski F-Score | Get a 7-Day Free Trial | 7.00 | 5.00 | 7.00 | 8.00 | 7.00 |
Global Cord Blood Quarterly Data | ||||||||||||||||||||
Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | |
Piotroski F-Score | Get a 7-Day Free Trial | 8.00 | - | - | - | 7.00 |
How is the Piotroski F-Score calculated?
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Mar22) TTM: | Last Year (Mar21) TTM: |
Net Income was $79.0 Mil. Cash Flow from Operations was $96.7 Mil. Revenue was $196.0 Mil. Gross Profit was $167.1 Mil. Average Total Assets from the begining of this year (Mar21) to the end of this year (Mar22) was (1214.322 + 1345.164) / 2 = $1279.743 Mil. Total Assets at the begining of this year (Mar21) was $1,214.3 Mil. Long-Term Debt & Capital Lease Obligation was $0.0 Mil. Total Current Assets was $1,093.1 Mil. Total Current Liabilities was $101.9 Mil. |
Net Income was $78.1 Mil. Revenue was $178.1 Mil. Gross Profit was $150.6 Mil. Average Total Assets from the begining of last year (Mar20) to the end of last year (Mar21) was (1028.396 + 1214.322) / 2 = $1121.359 Mil. Total Assets at the begining of last year (Mar20) was $1,028.4 Mil. Long-Term Debt & Capital Lease Obligation was $0.0 Mil. Total Current Assets was $967.3 Mil. Total Current Liabilities was $96.2 Mil. |
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Global Cord Blood's current Net Income (TTM) was 79.0.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Global Cord Blood's current Cash Flow from Operations (TTM) was 96.7.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Score 1 if it's higher, 0 if it's lower.
ROA (This Year) | = | Net Income | / | Total Assets (Mar21) |
= | 78.975 | / | 1214.322 | |
= | 0.06503629 |
ROA (Last Year) | = | Net Income | / | Total Assets (Mar20) |
= | 78.061 | / | 1028.396 | |
= | 0.07590559 |
Global Cord Blood's return on assets of this year was 0.06503629. Global Cord Blood's return on assets of last year was 0.07590559.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Score 1 if CFROA > ROA, 0 if CFROA <= ROA.
Global Cord Blood's current Net Income (TTM) was 79.0. Global Cord Blood's current Cash Flow from Operations (TTM) was 96.7.
==> 96.7 > 79.0 ==> CFROA > ROA ==> Score 1.
Funding
Question 5. Change in Gearing or Leverage
Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.
Score 0 if this year's gearing is higher, 1 otherwise.
Gearing (This Year: Mar22) | = | Long-Term Debt & Capital Lease Obligation | / | Average Total Assets from Mar21 to Mar22 |
= | 0 | / | 1279.743 | |
= | 0 |
Gearing (Last Year: Mar21) | = | Long-Term Debt & Capital Lease Obligation | / | Average Total Assets from Mar20 to Mar21 |
= | 0.023 | / | 1121.359 | |
= | 2.051E-5 |
Global Cord Blood's gearing of this year was 0. Global Cord Blood's gearing of last year was 2.051E-5.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Current Ratio (This Year: Mar22) | = | Total Current Assets | / | Total Current Liabilities |
= | 1093.056 | / | 101.907 | |
= | 10.7260149 |
Current Ratio (Last Year: Mar21) | = | Total Current Assets | / | Total Current Liabilities |
= | 967.323 | / | 96.218 | |
= | 10.05345154 |
Global Cord Blood's current ratio of this year was 10.7260149. Global Cord Blood's current ratio of last year was 10.05345154.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Global Cord Blood's number of shares in issue this year was 121.551. Global Cord Blood's number of shares in issue last year was 121.551.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Gross Margin (This Year: TTM) | = | Gross Profit | / | Revenue |
= | 167.063 | / | 195.955 | |
= | 0.85255799 |
Gross Margin (Last Year: TTM) | = | Gross Profit | / | Revenue |
= | 150.623 | / | 178.107 | |
= | 0.84568827 |
Global Cord Blood's gross margin of this year was 0.85255799. Global Cord Blood's gross margin of last year was 0.84568827.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Asset Turnover (This Year) | = | Revenue | / | Total Assets at the Beginning of This Year (Mar21) |
= | 195.955 | / | 1214.322 | |
= | 0.16136988 |
Asset Turnover (Last Year) | = | Revenue | / | Total Assets at the Beginning of Last Year (Mar20) |
= | 178.107 | / | 1028.396 | |
= | 0.17318912 |
Global Cord Blood's asset turnover of this year was 0.16136988. Global Cord Blood's asset turnover of last year was 0.17318912.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score | = | Que. 1 | + | Que. 2 | + | Que. 3 | + | Que. 4 | + | Que. 5 | + | Que. 6 | + | Que. 7 | + | Que. 8 | + | Que. 9 |
= | 1 | + | 1 | + | 0 | + | 1 | + | 1 | + | 1 | + | 1 | + | 1 | + | 0 | |
= | 7 |
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Global Cord Blood has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Global Cord Blood (OTCPK:CORBF) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Thank you for viewing the detailed overview of Global Cord Blood's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Kent C Mccarthy | 10 percent owner, other: Mbr 13(d) grp own 10% plus | 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451 |
Jayhawk Private Equity Fund Ii Lp | 10 percent owner | 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205 |
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010 | other: 13 (d) group owning > 10% | 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010 | 10 percent owner, other: Member of 13(d) group owning m | 7335 COTTONWOOD, SHAWNEE KS 66216 |
Mccarthy Family Sd, Llc | 10 percent owner, other: 13 (d) group owning > 10% | 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
Jhab Fund Ii, Llc | other: 13(d) group owning > 10% | 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
Jhab Management Ii, Llc | other: 13(d) group owning > 10% | 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216 |
Jcf Co Lf, L.p. | other: 13(d) group owning > 10% | 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451 |
Jayhawk Capital Management Llc | other: Member of the group | 13021 W 74TH ST, SHAWNEE KS 66216 |
Jayhawk China Fund Cayman Ltd | other: Member of the group | 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451 |
Jayhawk Private Equity Gp Ii, L.p. | 10 percent owner | 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205 |
Jayhawk Private Equity, Llc | 10 percent owner | 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205 |
From GuruFocus
By PRNewswire PRNewswire • 07-09-2022
By PRNewswire PRNewswire • 06-29-2022
By PRNewswire PRNewswire • 12-16-2021
By PRNewswire PRNewswire • 11-17-2021
By PRNewswire PRNewswire • 09-17-2021
By PRNewswire PRNewswire • 07-06-2022
By PRNewswire PRNewswire • 06-19-2022
By PRNewswire PRNewswire • 06-09-2022
By Business Wire Business Wire • 05-23-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.